Leaders in Science and Society - Dr Roberto Weigert
•
1 like•288 views
Dr. Roberto Weigert will give a presentation titled "Molecular Mechanism of Membrane remodeling in Live Animals by Subcellular Intravital Microscopy". He is a Senior Investigator at the National Cancer Institute and National Institute of Dental and Craniofacial Research. Using subcellular intravital microscopy, his research studies membrane remodeling during trafficking events in live animals.
Report
Share
Report
Share
Download to read offline
Recommended
George Liu senior thesis
This document discusses developing a deterministic lateral displacement (DLD) array to isolate exosomes, which are extracellular vesicles 50-100 nm in diameter that carry proteins and genetic material between cells. DLD uses arrays of pillars in microfluidic channels to separate particles by size: particles above a critical diameter are displaced laterally into different flow lanes than smaller particles. The author aims to design a "cascade array" DLD device with nanoscale features to separate exosomes and other nanoparticles. Challenges include increased diffusion effects at small scales that could reduce deterministic separation. Preliminary tests of nanoscale cascade arrays show potential for fractionating micro- and nanoparticles like exosomes.
Introduction to nanomaterials
Nanomaterials are materials synthesized at the nanoscale between 1-100nm. Their properties can differ greatly from their larger counterparts. For example, a gold coin is soft and yellow at normal scale but becomes hard and red at the nanoscale. Nanomaterials have many applications including in medicine for targeted drug delivery, in diagnostics like cancer detection, and in cosmetics like sunscreens with efficient UV protection. They can cross cell membranes and offer localized targeted delivery of drugs while maintaining drug solubility.
RSSSE poster
The document discusses the University of Nottingham's exhibit for the Royal Society Summer Science Exhibition focused on plastics used in the human body. The exhibit will showcase cutting edge research on polymers for drug delivery, medical devices, and controlling surface characteristics. It will provide interactive displays to educate visitors on how polymers are used beneficially in the body and the ongoing challenges and research at the University of Nottingham in these areas.
Mini symposium
This document summarizes a mini symposium discussing the integration of transcriptomics and proteomics. It includes three presentations: 1) Cancer Proteogenomics by Prof. David Fenyö discussing novel approaches for tumor proteogenomics and biomarker identification. 2) Protein identification based on ribosome targeted mRNA fragments by Dr. Gerben Menschaert discussing integrating ribosome profiling and mass spectrometry to provide information on protein synthesis. 3) Improved MS/MS peptide identification through Machine Learning by Dr. Sven Degroeve showing how machine learning can use peak intensity information in MS2 spectra to improve peptide identification sensitivity and accuracy.
Cancer Glycobiology
Diluka Peiris is a postdoctoral researcher who studies breast cancer glycobiology, proteomics, and biosensors to identify new targets for aggressive breast cancer. Her work focuses on identifying changes on the cancer cell surface that influence breast cancer's ability to spread to secondary organs. Specifically, she analyzes how the sugar composition of membrane proteins changes during metastasis and uses lectins and proteomics to identify differentially expressed proteins on metastatic cancer cells. Her goal is to develop these proteins into biomarkers for early diagnosis and future antibody treatments of metastatic breast cancer.
Cells
Eukaryotic cells contain membrane-bound organelles like the nucleus, endoplasmic reticulum, Golgi apparatus, mitochondria, chloroplasts, and vacuoles. Prokaryotic cells like bacteria and archaea contain organelles such as the plasma membrane, nucleoid region, ribosomes, cell wall, capsule, pili, and flagella. Both cell types share common organelles including the plasma membrane, cytoplasm, DNA, and ribosomes. The main differences are that eukaryotes have a nucleus with linear DNA while prokaryotes have circular DNA, and eukaryotes are generally larger in size and more complex than prokaryotes.
Unipi industry optofluidic microsystem based on photonic crystal and proced...
Unipi industry optofluidic microsystem based on photonic crystal and proced...Toscana Open Research
The present invention relates to an optofluidic microsystem based on photonic crystals and a process for its realisation.
Staging grading and spread of tumors
This document discusses the concepts of tumor staging, grading, and spread. It explains the invasion-metastasis cascade by which tumors invade surrounding tissue and spread to distant sites. The document outlines the four steps of tumor invasion into surrounding extracellular matrix. It also discusses factors that influence the organ sites that tumors preferentially metastasize to. The document describes tumor grading as estimating aggressiveness based on differentiation and mitoses, and tumor staging as assessing primary tumor size, lymph node involvement, and presence of metastases using the TNM system. Grading and staging are used to make accurate prognoses and compare treatment outcomes.
Recommended
George Liu senior thesis
This document discusses developing a deterministic lateral displacement (DLD) array to isolate exosomes, which are extracellular vesicles 50-100 nm in diameter that carry proteins and genetic material between cells. DLD uses arrays of pillars in microfluidic channels to separate particles by size: particles above a critical diameter are displaced laterally into different flow lanes than smaller particles. The author aims to design a "cascade array" DLD device with nanoscale features to separate exosomes and other nanoparticles. Challenges include increased diffusion effects at small scales that could reduce deterministic separation. Preliminary tests of nanoscale cascade arrays show potential for fractionating micro- and nanoparticles like exosomes.
Introduction to nanomaterials
Nanomaterials are materials synthesized at the nanoscale between 1-100nm. Their properties can differ greatly from their larger counterparts. For example, a gold coin is soft and yellow at normal scale but becomes hard and red at the nanoscale. Nanomaterials have many applications including in medicine for targeted drug delivery, in diagnostics like cancer detection, and in cosmetics like sunscreens with efficient UV protection. They can cross cell membranes and offer localized targeted delivery of drugs while maintaining drug solubility.
RSSSE poster
The document discusses the University of Nottingham's exhibit for the Royal Society Summer Science Exhibition focused on plastics used in the human body. The exhibit will showcase cutting edge research on polymers for drug delivery, medical devices, and controlling surface characteristics. It will provide interactive displays to educate visitors on how polymers are used beneficially in the body and the ongoing challenges and research at the University of Nottingham in these areas.
Mini symposium
This document summarizes a mini symposium discussing the integration of transcriptomics and proteomics. It includes three presentations: 1) Cancer Proteogenomics by Prof. David Fenyö discussing novel approaches for tumor proteogenomics and biomarker identification. 2) Protein identification based on ribosome targeted mRNA fragments by Dr. Gerben Menschaert discussing integrating ribosome profiling and mass spectrometry to provide information on protein synthesis. 3) Improved MS/MS peptide identification through Machine Learning by Dr. Sven Degroeve showing how machine learning can use peak intensity information in MS2 spectra to improve peptide identification sensitivity and accuracy.
Cancer Glycobiology
Diluka Peiris is a postdoctoral researcher who studies breast cancer glycobiology, proteomics, and biosensors to identify new targets for aggressive breast cancer. Her work focuses on identifying changes on the cancer cell surface that influence breast cancer's ability to spread to secondary organs. Specifically, she analyzes how the sugar composition of membrane proteins changes during metastasis and uses lectins and proteomics to identify differentially expressed proteins on metastatic cancer cells. Her goal is to develop these proteins into biomarkers for early diagnosis and future antibody treatments of metastatic breast cancer.
Cells
Eukaryotic cells contain membrane-bound organelles like the nucleus, endoplasmic reticulum, Golgi apparatus, mitochondria, chloroplasts, and vacuoles. Prokaryotic cells like bacteria and archaea contain organelles such as the plasma membrane, nucleoid region, ribosomes, cell wall, capsule, pili, and flagella. Both cell types share common organelles including the plasma membrane, cytoplasm, DNA, and ribosomes. The main differences are that eukaryotes have a nucleus with linear DNA while prokaryotes have circular DNA, and eukaryotes are generally larger in size and more complex than prokaryotes.
Unipi industry optofluidic microsystem based on photonic crystal and proced...
Unipi industry optofluidic microsystem based on photonic crystal and proced...Toscana Open Research
The present invention relates to an optofluidic microsystem based on photonic crystals and a process for its realisation.
Staging grading and spread of tumors
This document discusses the concepts of tumor staging, grading, and spread. It explains the invasion-metastasis cascade by which tumors invade surrounding tissue and spread to distant sites. The document outlines the four steps of tumor invasion into surrounding extracellular matrix. It also discusses factors that influence the organ sites that tumors preferentially metastasize to. The document describes tumor grading as estimating aggressiveness based on differentiation and mitoses, and tumor staging as assessing primary tumor size, lymph node involvement, and presence of metastases using the TNM system. Grading and staging are used to make accurate prognoses and compare treatment outcomes.
Final cecr presenation
The Center of Excellence in Cancer Research (CECR) was established in June 2013 at Tanta University Educational Hospital in Egypt. It is directed by Dr. Mohamed L. Salem and focuses on correlating immunologic and clinical data from genomic, transcriptomic, and proteomic profiling of circulating and primary tumor cells. The CECR has core facilities for flow cytometry, cell sorting, and genomic and proteomic analysis to support its research.
circFA Presentation for the Xilinx Open Hardware Contest 2018
This document discusses using an FPGA to accelerate DNA sequence alignment to help diagnose cancer patients faster. Circular RNAs show potential as biomarkers for cancers like lung cancer and have been correlated with diseases like osteosarcoma, bladder cancer, breast cancer, and Alzheimer's. An FPGA could help map fragments of circular RNAs to the human genome and compute the alignment matrix faster using tools like TOPHAT2 and Bowtie2. This accelerated aligner along with databases could enable tailored cancer therapies for more patients in reduced time by bringing new biological insights.
Bionanotechnology
Bionanotechnology involves utilizing biological systems at the nanoscale to develop functional nanostructures for various applications. It includes self-assembled nanostructures, bio-inspired materials, and using biological entities like viruses, ferritin proteins and DNA as templates to build nano-devices. Some key applications of bionanotechnology discussed are in medicine for targeted drug delivery, disease diagnosis, artificial photosynthesis, water treatment and military surveillance. However, developing this technology responsibly with consideration of ethical, legal and social implications will be important for public acceptance.
Magnetic Assisted Transfection
Magnet assisted transfection, also known as Magnetofection, is a simple and highly effective method to deliver biomolecules such as nucleic acids into cells using magnetic nanoparticles and magnetic fields. The process involves mixing biomolecules with magnetic nanoparticles, adding this complex to cells, and using a magnet array beneath the plate to draw the complex into the cells via endocytosis in a rapid and efficient manner without damaging the cells. The magnetic nanoparticles are then biodegraded, releasing the biomolecules into the cytoplasm.
Nano
Nanoparticles show promise for improving cancer diagnosis and treatment. They can be used to detect cancer by carrying imaging agents targeted to tumor biomarkers (A). For treatment, nanoparticles can deliver higher doses of chemotherapy drugs specifically to cancer cells, reducing toxicity to healthy cells (B). Biodegradable polymer nanoparticles have been designed to both target tumor cells using ligands, diagnose the cells, and release anticancer drugs inside the cells to treat the cancer (C). Overall, nanoparticles may enable more effective and less toxic cancer diagnosis and therapy by taking advantage of their small size and ability to be functionalized for targeting.
introduction to nanotechnology
The document discusses the technical textiles and nanotechnology course code TE-4203 taught by Dr. Abul Kalam at the National Institute of Textile Engineering and Research. The course covers an introduction to nanotechnology, the history and importance of nanotechnology, an overview of nanomaterials including their applications, the differences between bulk and nanomaterials, quantum dots and quantum effects, as well as the properties and building blocks of nanomaterials.
Nanotechnology
Nanotechnology shows great promise for advancing cancer diagnosis, treatment, and prevention. It allows detection and monitoring of cancer at the molecular level using nano-scale devices like nanowires and cantilevers. Therapeutics can be delivered via nanoparticles and nanoshells in a targeted manner to kill cancer cells while reducing side effects. Major challenges remain in developing robust multifunctional nanostructures and preventing and controlling cancer through early detection, proteomics, and interdisciplinary training.
University of Southampton - ORC seminar
Dr. Ogan Gurel will present on "Protein Electrodynamics & Terahertz Medicine: A New Frontier?". Proteins exhibit dynamic behavior with vibrations at terahertz frequencies that are essential to their function. These vibrations interact with electromagnetic radiation in the terahertz band, as confirmed by experiments showing specific absorption of terahertz radiation by met-hemoglobin. This suggests terahertz molecular medical imaging and manipulation of protein motions for new therapies. Dr. Gurel is a director at Samsung Advanced Institute of Technology with experience in biomedicine, biophysics, and computer science.
Genomics
Genomics is the study of whole genomes and incorporates elements of genetics. It examines an organism's full set of genes and interactions between genes, in contrast to classical genetics which focuses on individual genes. Genomics uses techniques like DNA sequencing and bioinformatics to analyze genome structure and function. Key tools in genomics include microarrays, which are slides containing thousands of DNA probes, and bioinformatics, which analyzes large genetic data sets. Microarrays are used in applications like cancer research and pharmacology.
Bionanotechnology introduction
This document discusses the history and concepts of bionanotechnology. It begins by outlining some of the early pioneers of nanotechnology, including Richard Feynman in the 1950s, Richard Smalley who developed buckyballs in the 1990s, and Eric Drexler who founded the field of molecular nanotechnology. It then defines bionanotechnology as the application of nanotechnology to biological and biomedical areas. The document discusses opportunities and challenges of bionanotechnology, such as using quantum dots for imaging and developing targeted drug delivery systems, while noting challenges like understanding long-term health impacts. It also outlines some key applications and features of nanotechnology for drug delivery.
cancer treatment using nanotechnology by RAMYA G
This document discusses using nanotechnology for cancer treatment. It describes how nanoparticles can target cancer cells due to their rapid growth and nutrient intake. Experiments showed that mice with human prostate tumors treated with nanoparticles targeted to cancer cells had a 100% survival rate, compared to 57% for untargeted nanoparticles and 14% for chemotherapy alone. Challenges include developing biocompatible nanoparticles that can target cancer cells without side effects. Future applications could include human trials in the next few years and managing cancer as a chronic disease in 15-20 years.
Nanotechnology in Cancer - Dr. Cote
Dr. Richard Cote of Sylvester Comprehensive Cancer Center presented "New Technologies That Will Have an Impact on Cancer" at the 2011 WellBeingWell Conference in Miami.
Lab-on-a-Chip for cancer diagnostics and monitoring
This document discusses lab-on-a-chip technology for cancer diagnostics and monitoring. It describes how lab-on-a-chip allows miniaturization of diagnostic tools to fit on a small chip. Examples are given of chips that can detect cancer markers from small samples of blood or other bodily fluids. The document outlines how lab-on-a-chip could provide frequent, non-invasive monitoring of cancer markers to guide treatment and detect recurrence. However, challenges remain in developing control units and integrating all necessary functions like fluid handling and molecular analysis onto a single chip.
3rd summary rise.
Nanotechnology involves manipulating materials at the nano scale and is being applied in fields like medicine, computing and manufacturing. It allows investigation of nanoparticles which provide high surface area and efficient dispersibility. Electrospinning is used to deposit nanomaterials and produces thin fibers through an electrical field between a polymer solution and collector. Sputtering places substrates in a vacuum chamber to produce nanoparticles by applying a negative charge to a target material and depositing the particles as a thin film on the substrates. Nanotechnology is being used in medicine through implants containing nanostructures to promote acceptance by surrounding cells, and may help create molecular systems equivalent to living systems to replace non-functional organs.
Nanotechnology in cancer therapy
This presentation is related to cancer treatment and involvement of the nanotechnology in cancer research. This has different nanotechnology-related delivery information.
Exosome pathway
Extracellular molecules, such as nucleotides, lipids, short peptides or proteins, are released by cells and bind to receptors on the other cells, which are important mediators in cell-to-cell communications in multicellular organisms. In addition to single molecules, eukaryotic cells can also release membrane vesicles into extracellular environment, such as microvesicles, apoptotic blebs and exosomes.
Tools of Genomics
The document discusses genomics, which is the study of an organism's entire genome, including all its genes and DNA. It defines key terms like genome and explains that genomics involves sequencing and analyzing genes at the DNA, mRNA, and protein levels. The document outlines different areas of genomics research like structural and functional genomics. It also discusses the goals of genomics and how genome sequencing is performed by breaking the genome into fragments that are then sequenced and pieced together.
Queensland Brain Institute
The Meunier laboratory at the Queensland Brain Institute had a productive year in 2013. They were awarded two grants to fund their research into neuronal communication and survival. In 2013, the laboratory published eight papers investigating topics like the role of myosin VI in neuroexocytosis and the regulation of neuroexocytosis by Munc18-1. They also demonstrated that inhibition of PIKfyve activity leads to neuronal cell death by disrupting autophagy, implicating this pathway in neurodegenerative diseases. The laboratory continued to study vesicular trafficking and collaborated with other researchers on projects involving neurotoxin transport in neurons and dynamin inhibitors.
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
The final goal of the project is to develop “BioBrick” for liposome produced by means of synthetic biology, that
has a construct for disintegration embedded in its membrane. Xenobiotic packaged in a liposome is not part
of pharmacodynamics since it is biologically unavailable. Which makes liposomes interesting candidates for
universal drug delivery vectors. In our case, liposome disintegration is initiated by non-invasive sonic signal
and carried out by a construct of a sensor and an active part embedded in a membrane. Sensor part of a
construct is mechanoreceptor/mechanotransducer which activates protein representing the active part of a
construct. After activation, active part carries out the dissolution of a compartmentalization function by means
of total disintegration of vector or only membrane perforation. After an opening of a vector, previously packed
xenobiotic becomes locally available with a high concentration in locale and thus high effect and low systemic
concentration and thus smaller chance of side effect. This approach is very specific for both, time and space
factors and at the same time has a very broad area of potential biomedical applications. Vector would be, in
a hypothetical scenario of practical use in oncology, first packed with chemotherapeutics/biological drugs,
administered intravenously and then medical staff would have an option of drug activation in specific locations.
Activation is very precise and at the same time offers an option of easy switching among many different
targets, for example between dominant tumor to many potential metastasis. Since location of activation is
not tied to biomarker, but rather takes advantage of other rapidly developing medical technologies, vector
remains universally and directly applicable for any patient and for a broad spectrum of pathologies in fields of
oncology (chemotherapeutics/biological drugs and other payloads, like local immune response enhancers),
autoimmune diseases (local immune suppressors, diabetes), parasitology (malaria drugs and plasmodium
sporozoite), local pathologies (ulcer, trauma healing) . . .
apoptosis cancer science
International Journal of Cancer Studies & Research (IJCR) ISSN:2167-9118 is a comprehensive, peer reviewed journal devoted to cancer studies and research. IJCR, published by SciDoc is an open access journal that includes high quality papers, which covers all major areas of Cancer and its related fields. SciDoc with its Open Access publication model spreads all the day-to-day developments and research to readers around the world.
NanoDelivery 2017_TP
This document contains information about the International Conference and Exhibition on Nanomedicine and Drug Delivery that will take place from May 29-31, 2017 in Osaka, Japan. It includes the tentative program agenda, speaker biographies, organizing committee members, and registration information. The conference will feature keynote lectures, interactive sessions, workshops, and tracks on topics related to nanomedicine and drug delivery over the three-day event.
Mark_Carr_CV_040914
This document provides a curriculum vitae for Professor Mark Carr, including his personal information, qualifications, employment history, research activities and interests, current research grants, other research activities, teaching responsibilities, administrative duties, and publications. Professor Carr is currently a Professor of Biochemistry and Director of Enterprise at the University of Leicester. His research focuses on determining protein structures and interactions involved in key biological processes and diseases. He leads a successful research group and has secured over £2.7 million in research funding.
More Related Content
What's hot
Final cecr presenation
The Center of Excellence in Cancer Research (CECR) was established in June 2013 at Tanta University Educational Hospital in Egypt. It is directed by Dr. Mohamed L. Salem and focuses on correlating immunologic and clinical data from genomic, transcriptomic, and proteomic profiling of circulating and primary tumor cells. The CECR has core facilities for flow cytometry, cell sorting, and genomic and proteomic analysis to support its research.
circFA Presentation for the Xilinx Open Hardware Contest 2018
This document discusses using an FPGA to accelerate DNA sequence alignment to help diagnose cancer patients faster. Circular RNAs show potential as biomarkers for cancers like lung cancer and have been correlated with diseases like osteosarcoma, bladder cancer, breast cancer, and Alzheimer's. An FPGA could help map fragments of circular RNAs to the human genome and compute the alignment matrix faster using tools like TOPHAT2 and Bowtie2. This accelerated aligner along with databases could enable tailored cancer therapies for more patients in reduced time by bringing new biological insights.
Bionanotechnology
Bionanotechnology involves utilizing biological systems at the nanoscale to develop functional nanostructures for various applications. It includes self-assembled nanostructures, bio-inspired materials, and using biological entities like viruses, ferritin proteins and DNA as templates to build nano-devices. Some key applications of bionanotechnology discussed are in medicine for targeted drug delivery, disease diagnosis, artificial photosynthesis, water treatment and military surveillance. However, developing this technology responsibly with consideration of ethical, legal and social implications will be important for public acceptance.
Magnetic Assisted Transfection
Magnet assisted transfection, also known as Magnetofection, is a simple and highly effective method to deliver biomolecules such as nucleic acids into cells using magnetic nanoparticles and magnetic fields. The process involves mixing biomolecules with magnetic nanoparticles, adding this complex to cells, and using a magnet array beneath the plate to draw the complex into the cells via endocytosis in a rapid and efficient manner without damaging the cells. The magnetic nanoparticles are then biodegraded, releasing the biomolecules into the cytoplasm.
Nano
Nanoparticles show promise for improving cancer diagnosis and treatment. They can be used to detect cancer by carrying imaging agents targeted to tumor biomarkers (A). For treatment, nanoparticles can deliver higher doses of chemotherapy drugs specifically to cancer cells, reducing toxicity to healthy cells (B). Biodegradable polymer nanoparticles have been designed to both target tumor cells using ligands, diagnose the cells, and release anticancer drugs inside the cells to treat the cancer (C). Overall, nanoparticles may enable more effective and less toxic cancer diagnosis and therapy by taking advantage of their small size and ability to be functionalized for targeting.
introduction to nanotechnology
The document discusses the technical textiles and nanotechnology course code TE-4203 taught by Dr. Abul Kalam at the National Institute of Textile Engineering and Research. The course covers an introduction to nanotechnology, the history and importance of nanotechnology, an overview of nanomaterials including their applications, the differences between bulk and nanomaterials, quantum dots and quantum effects, as well as the properties and building blocks of nanomaterials.
Nanotechnology
Nanotechnology shows great promise for advancing cancer diagnosis, treatment, and prevention. It allows detection and monitoring of cancer at the molecular level using nano-scale devices like nanowires and cantilevers. Therapeutics can be delivered via nanoparticles and nanoshells in a targeted manner to kill cancer cells while reducing side effects. Major challenges remain in developing robust multifunctional nanostructures and preventing and controlling cancer through early detection, proteomics, and interdisciplinary training.
University of Southampton - ORC seminar
Dr. Ogan Gurel will present on "Protein Electrodynamics & Terahertz Medicine: A New Frontier?". Proteins exhibit dynamic behavior with vibrations at terahertz frequencies that are essential to their function. These vibrations interact with electromagnetic radiation in the terahertz band, as confirmed by experiments showing specific absorption of terahertz radiation by met-hemoglobin. This suggests terahertz molecular medical imaging and manipulation of protein motions for new therapies. Dr. Gurel is a director at Samsung Advanced Institute of Technology with experience in biomedicine, biophysics, and computer science.
Genomics
Genomics is the study of whole genomes and incorporates elements of genetics. It examines an organism's full set of genes and interactions between genes, in contrast to classical genetics which focuses on individual genes. Genomics uses techniques like DNA sequencing and bioinformatics to analyze genome structure and function. Key tools in genomics include microarrays, which are slides containing thousands of DNA probes, and bioinformatics, which analyzes large genetic data sets. Microarrays are used in applications like cancer research and pharmacology.
Bionanotechnology introduction
This document discusses the history and concepts of bionanotechnology. It begins by outlining some of the early pioneers of nanotechnology, including Richard Feynman in the 1950s, Richard Smalley who developed buckyballs in the 1990s, and Eric Drexler who founded the field of molecular nanotechnology. It then defines bionanotechnology as the application of nanotechnology to biological and biomedical areas. The document discusses opportunities and challenges of bionanotechnology, such as using quantum dots for imaging and developing targeted drug delivery systems, while noting challenges like understanding long-term health impacts. It also outlines some key applications and features of nanotechnology for drug delivery.
cancer treatment using nanotechnology by RAMYA G
This document discusses using nanotechnology for cancer treatment. It describes how nanoparticles can target cancer cells due to their rapid growth and nutrient intake. Experiments showed that mice with human prostate tumors treated with nanoparticles targeted to cancer cells had a 100% survival rate, compared to 57% for untargeted nanoparticles and 14% for chemotherapy alone. Challenges include developing biocompatible nanoparticles that can target cancer cells without side effects. Future applications could include human trials in the next few years and managing cancer as a chronic disease in 15-20 years.
Nanotechnology in Cancer - Dr. Cote
Dr. Richard Cote of Sylvester Comprehensive Cancer Center presented "New Technologies That Will Have an Impact on Cancer" at the 2011 WellBeingWell Conference in Miami.
Lab-on-a-Chip for cancer diagnostics and monitoring
This document discusses lab-on-a-chip technology for cancer diagnostics and monitoring. It describes how lab-on-a-chip allows miniaturization of diagnostic tools to fit on a small chip. Examples are given of chips that can detect cancer markers from small samples of blood or other bodily fluids. The document outlines how lab-on-a-chip could provide frequent, non-invasive monitoring of cancer markers to guide treatment and detect recurrence. However, challenges remain in developing control units and integrating all necessary functions like fluid handling and molecular analysis onto a single chip.
3rd summary rise.
Nanotechnology involves manipulating materials at the nano scale and is being applied in fields like medicine, computing and manufacturing. It allows investigation of nanoparticles which provide high surface area and efficient dispersibility. Electrospinning is used to deposit nanomaterials and produces thin fibers through an electrical field between a polymer solution and collector. Sputtering places substrates in a vacuum chamber to produce nanoparticles by applying a negative charge to a target material and depositing the particles as a thin film on the substrates. Nanotechnology is being used in medicine through implants containing nanostructures to promote acceptance by surrounding cells, and may help create molecular systems equivalent to living systems to replace non-functional organs.
Nanotechnology in cancer therapy
This presentation is related to cancer treatment and involvement of the nanotechnology in cancer research. This has different nanotechnology-related delivery information.
Exosome pathway
Extracellular molecules, such as nucleotides, lipids, short peptides or proteins, are released by cells and bind to receptors on the other cells, which are important mediators in cell-to-cell communications in multicellular organisms. In addition to single molecules, eukaryotic cells can also release membrane vesicles into extracellular environment, such as microvesicles, apoptotic blebs and exosomes.
Tools of Genomics
The document discusses genomics, which is the study of an organism's entire genome, including all its genes and DNA. It defines key terms like genome and explains that genomics involves sequencing and analyzing genes at the DNA, mRNA, and protein levels. The document outlines different areas of genomics research like structural and functional genomics. It also discusses the goals of genomics and how genome sequencing is performed by breaking the genome into fragments that are then sequenced and pieced together.
Queensland Brain Institute
The Meunier laboratory at the Queensland Brain Institute had a productive year in 2013. They were awarded two grants to fund their research into neuronal communication and survival. In 2013, the laboratory published eight papers investigating topics like the role of myosin VI in neuroexocytosis and the regulation of neuroexocytosis by Munc18-1. They also demonstrated that inhibition of PIKfyve activity leads to neuronal cell death by disrupting autophagy, implicating this pathway in neurodegenerative diseases. The laboratory continued to study vesicular trafficking and collaborated with other researchers on projects involving neurotoxin transport in neurons and dynamin inhibitors.
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
The final goal of the project is to develop “BioBrick” for liposome produced by means of synthetic biology, that
has a construct for disintegration embedded in its membrane. Xenobiotic packaged in a liposome is not part
of pharmacodynamics since it is biologically unavailable. Which makes liposomes interesting candidates for
universal drug delivery vectors. In our case, liposome disintegration is initiated by non-invasive sonic signal
and carried out by a construct of a sensor and an active part embedded in a membrane. Sensor part of a
construct is mechanoreceptor/mechanotransducer which activates protein representing the active part of a
construct. After activation, active part carries out the dissolution of a compartmentalization function by means
of total disintegration of vector or only membrane perforation. After an opening of a vector, previously packed
xenobiotic becomes locally available with a high concentration in locale and thus high effect and low systemic
concentration and thus smaller chance of side effect. This approach is very specific for both, time and space
factors and at the same time has a very broad area of potential biomedical applications. Vector would be, in
a hypothetical scenario of practical use in oncology, first packed with chemotherapeutics/biological drugs,
administered intravenously and then medical staff would have an option of drug activation in specific locations.
Activation is very precise and at the same time offers an option of easy switching among many different
targets, for example between dominant tumor to many potential metastasis. Since location of activation is
not tied to biomarker, but rather takes advantage of other rapidly developing medical technologies, vector
remains universally and directly applicable for any patient and for a broad spectrum of pathologies in fields of
oncology (chemotherapeutics/biological drugs and other payloads, like local immune response enhancers),
autoimmune diseases (local immune suppressors, diabetes), parasitology (malaria drugs and plasmodium
sporozoite), local pathologies (ulcer, trauma healing) . . .
apoptosis cancer science
International Journal of Cancer Studies & Research (IJCR) ISSN:2167-9118 is a comprehensive, peer reviewed journal devoted to cancer studies and research. IJCR, published by SciDoc is an open access journal that includes high quality papers, which covers all major areas of Cancer and its related fields. SciDoc with its Open Access publication model spreads all the day-to-day developments and research to readers around the world.
What's hot (20)
circFA Presentation for the Xilinx Open Hardware Contest 2018
circFA Presentation for the Xilinx Open Hardware Contest 2018
Lab-on-a-Chip for cancer diagnostics and monitoring
Lab-on-a-Chip for cancer diagnostics and monitoring
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Sonogenetic Locale Specific Activation of Universal Vectors for Xenobiotics -...
Similar to Leaders in Science and Society - Dr Roberto Weigert
NanoDelivery 2017_TP
This document contains information about the International Conference and Exhibition on Nanomedicine and Drug Delivery that will take place from May 29-31, 2017 in Osaka, Japan. It includes the tentative program agenda, speaker biographies, organizing committee members, and registration information. The conference will feature keynote lectures, interactive sessions, workshops, and tracks on topics related to nanomedicine and drug delivery over the three-day event.
Mark_Carr_CV_040914
This document provides a curriculum vitae for Professor Mark Carr, including his personal information, qualifications, employment history, research activities and interests, current research grants, other research activities, teaching responsibilities, administrative duties, and publications. Professor Carr is currently a Professor of Biochemistry and Director of Enterprise at the University of Leicester. His research focuses on determining protein structures and interactions involved in key biological processes and diseases. He leads a successful research group and has secured over £2.7 million in research funding.
CV E Dupont sep 2015 academic
This document is a curriculum vitae for Emmanuel Dupont. It provides biographical information such as his date of birth, education history, employment history, research interests, teaching experience, and publications. His research has focused on gap junctions and their role in cell-to-cell communication, particularly in relation to the cardiovascular system.
Big Data & Immunotherapeutics Symposium Program
This document provides an agenda and program details for a symposium on advances in childhood cancer hosted by Kids Cancer Alliance (KCA). The free event will be held on August 31, 2018 at the Australian National Maritime Museum and will feature talks on topics such as clinical application of whole genome sequencing, analysis of big data in pediatric cancers, cancer epigenetics, immunotherapies including CAR T cell therapy, and high dimensional analysis of single cell proteome data. Speakers include researchers from Australia, the US, and Switzerland with expertise in areas like cancer genomics, bioinformatics, immunology, and data science.
Foresight in medicine: research induced society changes in the next decade
This document announces a symposium at the Embassy of Italy on advances in personalized medicine and their social impacts. The symposium will feature panels of scientists and policymakers discussing topics like how personalized medicine will change healthcare delivery and clinical practice in areas like cancer and neurodegenerative diseases. Emerging technologies in areas like imaging, nanotechnology, and mobile health will enable personalized care but also raise issues around ethics, regulation, and ensuring equitable access. The one-day event aims to identify key medical advances in the next decade and their implications for individuals and healthcare systems.
Advances in Cancer Stem Cell Biology
All about Cancer Stem Cell, pathogenetic, diagnostic & prognostic biomarker, therapeutic approaches. All you want to know about cancer stem cells & how to diagnose & treat them
PLEGABLE BIOLOGIA MOLECULAR 2012
1. Researchers have developed a new method for more efficiently labeling proteins that is faster, higher yielding, and less disruptive to protein and cell function than current methods.
2. They engineered mammalian cells to incorporate an artificial chemical handle that allows a small fluorescent molecule to rapidly and stably attach to proteins of interest, enabling new types of cell biological studies.
3. Understanding protein interactions with nanomaterials at the nanoscale is important for controlling their function in applications like biosensing and tissue engineering, and for developing new composite materials.
Applying the Proteomic-Bioinformatics strength to strengthen research
Proteomics-2013 conference by OMICS Group which is during July 15-17, 2013 at Courtyard by Marriott Philadelphia Downtown, USA has been appreciated with a huge gathering from more-than 30 countries.
ADVANCED CYTOMETRY SOLUTIONS-13
Dr. Edwin Walker received his PhD in cellular immunology in 1982 and completed postdoctoral research in flow cytometry. He held faculty positions focusing on flow cytometry and was director of several core flow cytometry laboratories. In 2013, he started Advanced Cytometry Solutions LLC to promote the use of advanced polychromatic flow cytometry in the biopharmaceutical industry for applications such as cancer immunotherapy research.
InKForge Launch Event - 17 January 2012 - The University of Sheffield
Industrial Knowledge Forge partnering with industry to develop the next generation of research leaders - I was invited to participate at the event.
Department of Biochemistry Newsletter September 2011
The document provides an overview of the Department of Biochemistry at the University of Johannesburg in South Africa. It details that the department has grown since becoming independent in 2005, now employing highly qualified academic staff conducting internationally competitive research. The department teaches undergraduate and postgraduate courses and supports 26 Masters and PhD students. Research areas include human genetics, infectious diseases, and plant-microbe interactions. Students regularly win awards and collaborate internationally.
CV Gabriella Di Stefano 4 feb 2016
Gabriella Di Stefano has over 15 years of experience in research and instruction. She holds a PhD in Translational Medicine from the University of L'Aquila and has worked as a research scholar at Case Western Reserve University. Her research focuses on skin wound healing, platelet rich plasma, and inflammatory bowel diseases. She has published papers in peer-reviewed journals and presented her work at conferences.
khouryintroourauthors
This document introduces several researchers and summarizes their work. It provides brief biographies of Omar Akbari, Nichole Daringer, Rachel Dudek, Kei Fujiwara, Amar Ghodasara, George Khoury, and Joshua Leonard. It summarizes each of their current positions, education, non-scientific interests, and research focus. The research focuses include developing genetic control technologies for reducing mosquito-borne diseases, engineering cell-based biosensors, developing biosensor platforms in mammalian cells, constructing replicative artificial cells, controlling gene expression in prokaryotes, protein engineering and designing inhibitors, and integrating synthetic biology with systems biology.
Massimo Cristofanilli -Biography.2015(2)
Massimo Cristofanilli is an Italian oncologist known for his research on inflammatory breast cancer (IBC) and circulating tumor cells (CTCs). He established the first IBC research program and international conference. His seminal research demonstrated that CTC detection provides prognostic information in metastatic breast cancer. This led to FDA approval of the first CTC test and recognition of CTCs role in metastasis. Currently, he directs efforts applying precision medicine approaches using blood-based molecular diagnostics to advance individualized treatment of breast cancer.
invivo30_web
The Barcelona Institute of Science and Technology was formally launched, bringing together six top Catalan research centers: CRG, ICIQ, ICN2, ICFO, IFAE, and IRB Barcelona. The new institution aims to foster interdisciplinary research, leverage scientific impact, and position itself among leading European research institutions. Angel Nebreda of IRB Barcelona received a Proof of Concept grant from the European Research Council to investigate new breast cancer therapies based on p38 MAPK inhibitors using patient samples. IRB Barcelona hosted the 15th European Light Microscopy Initiative meeting, bringing together over 400 microscopy experts to discuss the latest developments in microscopy techniques.
Models of Human Diseases Conference 2010 oral presentations abstracts
1st International Conference Models of Human Diseases oral presentations abstracts feature recent findings in development or emplyment of various models of diseases to advance biomedical research.
Artifial Organs
Dr. Jan Wojcicki is an expert in artificial organ research, particularly related to artificial pancreas and diabetes treatment. He has over 30 years of experience in this field and has authored over 300 publications. His research has focused on developing new monitoring technologies to improve diabetes therapy and patient outcomes. As an expert in the field, he will now serve as co-editor of Eastern Europe for the journal Artificial Organs to provide guidance and promote artificial organ research in the region.
Artifical Organs
Dr. Jan Wojcicki is an expert in artificial organ research, particularly related to artificial pancreas and diabetes treatment. He has over 30 years of experience in this field and has authored over 300 publications. His research has focused on developing new monitoring technologies to improve diabetes therapy and patient outcomes. As the new co-editor of Eastern Europe for Artificial Organs, he will provide guidance on the journal's operations in that region and promote artificial organ technologies.
Artificial Organs
Dr. Jan Wojcicki is an expert in artificial organ research, particularly related to artificial pancreas and diabetes treatment. He has over 30 years of experience in this field and has authored over 300 publications. His research has focused on developing new monitoring technologies to improve diabetes therapy and patient outcomes. As an expert in the field, he will now serve as co-editor of Eastern Europe for the journal Artificial Organs to provide guidance and promote artificial organ research in the region.
jln cv may 2016
Judith Luber-Narod has extensive experience in cellular and molecular pharmacology, in vitro toxicology, neuroimmunology, autoimmunity, oncology, and engineering. She has held positions as an industrial scientist, academic scientist, professor, and high school teacher. Her background includes research in various areas including neuroscience, immunology, toxicology, and oncology. She has authored several publications and holds patents in areas related to her work.
Similar to Leaders in Science and Society - Dr Roberto Weigert (20)
Foresight in medicine: research induced society changes in the next decade
Foresight in medicine: research induced society changes in the next decade
Applying the Proteomic-Bioinformatics strength to strengthen research
Applying the Proteomic-Bioinformatics strength to strengthen research
InKForge Launch Event - 17 January 2012 - The University of Sheffield
InKForge Launch Event - 17 January 2012 - The University of Sheffield
Department of Biochemistry Newsletter September 2011
Department of Biochemistry Newsletter September 2011
Models of Human Diseases Conference 2010 oral presentations abstracts
Models of Human Diseases Conference 2010 oral presentations abstracts
More from Garvan Institute of Medical Research
Leaders in Science and Society - Prof Gail Risbridger
Professor Gail Risbridger. Deputy Dean - Special Projects, MpCCC Research Director, Prostate Cancer Research Program, Monash University. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Scientia Prof Katharina Gaus
Scientia Professor Katharina Gaus - EMBL Australia Node in Single Molecule Science, ARC Centre of Excellence in Advanced Molecular Imaging, University of New South Wales. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Dr Kate Schroder
Dr Kate Schroder - Deputy Director, IMB Centre for Inflammation and Disease Research, Institute for Molecular Bioscience. http://www.garvan.org.au/news-events/leaders-in-science-and-societ
Leaders in Science and Society - Dr Markus Elsner
Markus Elsner, PhD - Senior Editor, Nature Biotechnology. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Ms Anna Bligh
Ms Anna Bligh - Chief Executive Officer, YWCA NSW. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Garvan Diabetes Symposium: 'Recent Advances in Metabolic Diseases'
Garvan Diabetes Symposium: 'Recent Advances in Metabolic Diseases'Garvan Institute of Medical Research
Professor Philip E Scherer, Touchstone Diabetes Center, UT Southwestern Medical Center, Dallas // Assistant Professor Janelle Ayres, Nomis Center for Immunobiology & Microbial Pathogenesis, The Salk Institute of Biological Studies // Professor Jorge Ferrer, Faculty of Medicine, Department of Medicine, Imperial College LondonLeaders in Science and Society - Mr Bill Ferris
Mr Bill Ferris AC, Chair of Innovation and Science Australia. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Louisa Jorm
Professor Louisa Jorm - Director, Centre for Big Data Research in Health, UNSW Australia. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Christina Mitchell
Professor Christina Mitchell will give a presentation titled "Regulation of Phosphoinositide 3-kinase signaling by Phosphoinositide Phosphatases" on June 20th at 12PM in the Auditorium. Professor Mitchell is the Academic Vice-President and Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University. She trained as a physician scientist specializing in clinical haematology and was the first woman appointed Dean of Medicine at a Group of Eight university in Australia.
Leaders in Science and Society - Prof Richard Gibbs
Prof Richard Gibbs - Director, Baylor College of Medicine Human Genome Sequencing Centre
Wofford Cain Professor of Human & Molecular Genetics. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - David Thodey
Mr David Thodey - Chairman, CSIRO. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Mr Charles Curran AC, LLB, FCPA
Leaders in Science and Society - Mr Charles Curran AC, LLB, FCPAGarvan Institute of Medical Research
Charles Curran, who has extensive experience in Australian business and public life, will give a talk reflecting on economic and political developments in Australia over the last 50 years. As the Chairman of Capital Investment Group and a member of Goldman Sachs' International Board of Advisors, Curran has chaired or been a director of several public companies. He has also held leadership roles in many community organizations, including as Chairman of the Garvan Institute of Medical Research and St Vincent's Hospital Sydney.Leaders in Science and Society - Prof Yoshihide Hayashizaki
Professor Yoshihide Hayashizaki, Program Director, Preventative Medicine and Diagnosis Innovation
Program, RIKEN, Japan. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Peter Vogt
Peter Vogt, a professor at The Scripps Research Institute, will give a lecture titled "MYC and the Non-coding Transcriptome" at the Garvan Institute of Medical Research on November 9, 2015. Vogt was trained as a virologist in Germany and California and his work focuses on retroviral replication, viral and cellular oncogenes, and identifying inhibitors of oncoproteins. He has held faculty positions at several universities and is currently a professor at The Scripps Research Institute studying MYC and non-coding RNA transcripts.
Leaders in Science and Society - Prof Rob Parton
Professor Rob Parton - Institute for Molecular Bioscience
University of Queensland. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Rodney Phillips
Prof Rodney Phillips - Dean, UNSW Medicine, FMedSci MA (Oxon) MD FRCP FRACP. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Carolyn Sue
Professor Carolyn Sue, Professor University of Sydney / Director of the Department of Neurogenetics at Royal North Shore Hospital / Director of the National Centre for Adult Stem Cell Research (Sydney Node). http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Joe Trapani
Professor Joe Trapani, Executive Director Cancer Research,
Peter MacCallum Cancer Centre, Melbourne. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Alain Fischer
Professor Alain Fischer, Hospital Necker (Paris). http://www.garvan.org.au/news-events/leaders-in-science-and-society
Leaders in Science and Society - Prof Ian Jacobs
Professor Ian Jacobs, President and Vice-Chancellor UNSW Australia. http://www.garvan.org.au/news-events/leaders-in-science-and-society
More from Garvan Institute of Medical Research (20)
Leaders in Science and Society - Prof Gail Risbridger
Leaders in Science and Society - Prof Gail Risbridger
Leaders in Science and Society - Scientia Prof Katharina Gaus
Leaders in Science and Society - Scientia Prof Katharina Gaus
Garvan Diabetes Symposium: 'Recent Advances in Metabolic Diseases'
Garvan Diabetes Symposium: 'Recent Advances in Metabolic Diseases'
Leaders in Science and Society - Prof Christina Mitchell
Leaders in Science and Society - Prof Christina Mitchell
Leaders in Science and Society - Prof Richard Gibbs
Leaders in Science and Society - Prof Richard Gibbs
Leaders in Science and Society - Mr Charles Curran AC, LLB, FCPA
Leaders in Science and Society - Mr Charles Curran AC, LLB, FCPA
Leaders in Science and Society - Prof Yoshihide Hayashizaki
Leaders in Science and Society - Prof Yoshihide Hayashizaki
Leaders in Science and Society - Prof Rodney Phillips
Leaders in Science and Society - Prof Rodney Phillips
Leaders in Science and Society - Prof Alain Fischer
Leaders in Science and Society - Prof Alain Fischer
Recently uploaded
Applied Science: Thermodynamics, Laws & Methodology.pdf
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Pests of Storage_Identification_Dr.UPR.pdf
InIndia-post-harvestlosses-unscientificstorage,insects,rodents,micro-organismsetc.,accountforabout10percentoftotalfoodgrains
Graininfestation
Directdamage
Indirectly
•theexuviae,skin,deadinsects
•theirexcretawhichmakefoodunfitforhumanconsumption
About600speciesofinsectshavebeenassociatedwithstoredgrainproducts
100speciesofinsectpestsofstoredproductscauseeconomiclosses
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
学校原件一模一样【微信：741003700 】《(salfor毕业证书)索尔福德大学毕业证》【微信：741003700 】学位证，留信认证（真实可查，永久存档）原件一模一样纸张工艺/offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原。
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
【主营项目】
一.毕业证【q微741003700】成绩单、使馆认证、教育部认证、雅思托福成绩单、学生卡等！
二.真实使馆公证(即留学回国人员证明,不成功不收费)
三.真实教育部学历学位认证（教育部存档！教育部留服网站永久可查）
四.办理各国各大学文凭(一对一专业服务,可全程监控跟踪进度)
如果您处于以下几种情况：
◇在校期间，因各种原因未能顺利毕业……拿不到官方毕业证【q/微741003700】
◇面对父母的压力，希望尽快拿到；
◇不清楚认证流程以及材料该如何准备；
◇回国时间很长，忘记办理；
◇回国马上就要找工作，办给用人单位看；
◇企事业单位必须要求办理的
◇需要报考公务员、购买免税车、落转户口
◇申请留学生创业基金
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
The binding of cosmological structures by massless topological defects
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.The cost of acquiring information by natural selection
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
8.Isolation of pure cultures and preservation of cultures.pdf
Isolation of pure culture, its various method.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.Micronuclei test.M.sc.zoology.fisheries.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
Immersive Learning That Works: Research Grounding and Paths Forward
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
ESR spectroscopy in liquid food and beverages.pptx
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureInternational Food Policy Research Institute- South Asia Office
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
11.1 Role of physical biological in deterioration of grains.pdf
Storagedeteriorationisanyformoflossinquantityandqualityofbio-materials.
Themajorcausesofdeteriorationinstorage
•Physical
•Biological
•Mechanical
•Chemical
Storageonlypreservesquality.Itneverimprovesquality.
Itisadvisabletostartstoragewithqualityfoodproduct.Productwithinitialpoorqualityquicklydepreciates
Recently uploaded (20)
Applied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdf
The binding of cosmological structures by massless topological defects
The binding of cosmological structures by massless topological defects
Basics of crystallography, crystal systems, classes and different forms
Basics of crystallography, crystal systems, classes and different forms
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
The cost of acquiring information by natural selection
The cost of acquiring information by natural selection
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...
Immersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths Forward
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
11.1 Role of physical biological in deterioration of grains.pdf
11.1 Role of physical biological in deterioration of grains.pdf
Leaders in Science and Society - Dr Roberto Weigert
- 1. Garvan Institute of Medical Research Leaders in Science & Society Dr Roberto Weigert Senior Investigator, Laboratory of Cellular and Molecular Biology, CCR – NCI Adjunct Investigator, Intracellular Membrane Trafficking Section, NIDCR National Institutes of Health “Molecular Mechanism of Membrane remodeling in Live Animals by Subcellular Intravital Microscopy” Monday 11 April 2016 12PM, AUDITORIUM Host: Dr Dan Hesselson Roberto Weigert, Ph.D. is a Senior investigator in the Laboratory of Cellular and Molecular Biology (LCMB), at the National Cancer Institute (NCI), Center for Cancer Research (CCR) and Chief of the Intracellular Membrane Trafficking Section in the National Institute of Dental and Craniofacial Research (NIDCR), at the National Institutes of Health (NIH). Dr. Weigert got his B.Sc. in chemistry in 1992 at the University of Catania (Italy). He joined the Department of Cell Biology at the Mario Negri Institute (Dr. Alberto Luini), where he studied the mechanism of formation of transport intermediates from the Golgi apparatus. He received his Ph.D. in 2000 from the Open University of London and in 2001 joined the National Heart, Lung and Blood Institute at NIH as a research fellow in the Laboratory of Cell Biology (Dr. Julie Donaldson). During his fellowship, Dr. Weigert studied the machinery regulating clathrin-independent endocytic pathways. In 2006, he joined the NIDCR as principal investigator, where he pioneered subcellular intravital microscopy to study various aspects of membrane remodeling during trafficking events in live animals. He was tenured in 2014 and in 2015 he joined LCMB at NCI